Cargando…
SAT-LB056 Is AIP a Tumor Suppressor or an Oncogene? AIP as a Novel Regulator of the Oncogene BCL6 in Diffuse Large B Cell Lymphoma
Background: Heterozygous germline loss-of-function mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene are usually associated with acromegaly or gigantism due to a young-onset somatotropinoma. AIP functions as a tumor suppressor gene in the pituitary, while its role in other tu...
Autores principales: | BARRY, SAYKA, Sun, Dijue, Stopka-Farooqui, Urszula, Aksoy, Ezra, Parsonage, Gregory, Vossenkamper, Anna, Capasso, Melania, Wan, Xinyu, Norris, Sherine, Marshall, Jennifer, Clear, Andrew, Gribben, John, MacDonald, Thomas, Buckley, Christopher, Korbonits, Marta, Haworth, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551993/ http://dx.doi.org/10.1210/js.2019-SAT-LB056 |
Ejemplares similares
-
Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 Degradation
por: Sun, Dijue, et al.
Publicado: (2019) -
Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors
por: Barry, Sayka, et al.
Publicado: (2019) -
AIP variant causing familial prolactinoma
por: Carty, David M., et al.
Publicado: (2020) -
Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland
por: Hernández-Ramírez, Laura C., et al.
Publicado: (2018) -
AIP Annual Meeting
por: Abashian, Alexander
Publicado: (1984)